"Listing gives DoW sustainment teams a direct path to AI supply chain decision intelligence platform to improve aircraft availability across all Services"PALO ALTO, Calif.,...
Canada's Retail Sector Recognizes Its Best at Annual ERA GalaTORONTO, June 2, 2026 /CNW/ - From AI-powered shopping tools to automated fulfillment and immersive in-store...
AUSTIN, Minn., June 2, 2026 /PRNewswire/ -- Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, announced today that John Ghingo,...
Sydney, Australia, June 02, 2026 (GLOBE NEWSWIRE) -- With the Reserve Bank of Australia cash rate at 4.35% and annual inflation running at 4.6% in the year to March 2026, self-managed super fund trustees are under pressure to find income that keeps pace with the rising cost of living. Australian Taxation Office data shows SMSF allocations to cash and deposit products have fallen to 16.3% of sector holdings, a record low, as trustees look beyond traditional cash products for the income side of the portfolio. One category drawing attention is fixed-term investment accounts underpinned by global private credit, an asset class that has reached US$3.5 trillion globally, according to the Alternative Credit Council's Financing the Economy 2025 report, and has been one of the fastest-growing asset classes in the world over the last 15+ years. To learn mroe visit https://termplus.com.au/term-account-smsf/
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Qiagen N.V. (“Qiagen” or the “Company”) (NYSE: QGEN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
OTTAWA, Ontario, June 02, 2026 (GLOBE NEWSWIRE) -- The Canadian Animal Health Institute (CAHI) is proud to announce the recipients of its 2026 Annual Awards, recognizing exceptional leadership and contributions to Canada’s animal health sector.
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.